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In various studies nicotine has shown to alter cognitive functions in non-smoking sub-
jects. The physiological basis for these effects might be nicotine-generated modulation of
cortical structure, excitability, and activity, as mainly described in animal experiments. In
accordance, a recently conducted study demonstrated that application of nicotine for hours
via nicotine patch in non-smoking humans alters the effects of neuroplasticity-inducing
non-invasive brain stimulation techniques on cortical excitability. Specifically, nicotine abol-
ished inhibitory plasticity independent from the focality of the stimulation protocol. While
nicotine prevented also the establishment of non-focal facilitatory plasticity, focal synapse-
specific facilitatory plasticity was enhanced. These results agree with a focusing effect of
prolonged nicotine application on facilitatory plasticity. However, since nicotine induces
rapid adaption processes of its receptors, this scenario might differ from the effect of
nicotine in cigarette smoking. Thus in this study we aimed to gain further insight in the
mechanism of nicotine on plasticity by exploring the effect of nicotine spray on non-focal
and focal plasticity-inducing protocols in non-smoking subjects, a fast-acting agent better
comparable to cigarette smoking. Focal, synapse-specific plasticity was induced by paired
associative stimulation (PAS), while non-focal plasticity was elicited by transcranial direct
current stimulation (tDCS). Forty eight non-smokers received nicotine spray respectively
placebo combined with one of the following protocols (anodal tDCS, cathodal tDCS, PAS-25,
and PAS-10). Corticospinal excitability was monitored via motor-evoked potentials elicited
by transcranial magnetic stimulation (TMS). Nicotine spray abolished facilitatory plastic-
ity irrespective of focality and PAS-10-induced excitability diminution, while tDCS-derived
excitability reduction was delayed and weakened. Nicotine spray had thus a clear effect on
neuroplasticity in non-smoking subjects. However, the effects of nicotine spray differ clearly
from those of prolonged nicotine application, which might be due to missing adaptive nico-
tinic receptor alterations.These results enhance our knowledge about the dynamic impact
of nicotine on plasticity, which might be related to its heterogenous effect on cognition.
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INTRODUCTION
Nicotine binds to the nicotinergic type of cholinergic receptors,
which are ligand-gated cation channels. Nicotine also affects other
transmitter systems by regulating the release of dopamine, adren-
aline, serotonin, and glutamate, amongst others. Hereby nicotine
is thought to be critically involved in the induction and mod-
ulation of neuroplasticity (Burnashev, 1998; Dajas-Bailador and
Wonnacott, 2004; Levin et al., 2006), the likely physiological basis
of learning and memory formation (Rioult-Pedotti et al., 1998,
2000). Specifically, in animal experiments the activation of nico-
tinic receptors results in a facilitation of long-term potentation
(LTP), both dependent and independent of NMDA-receptor acti-
vation (Sawada et al., 1994; Huerta and Lisman, 1995; Matsuyama
et al., 2000).
COGNITIVE EFFECTS OF NICOTINE
On a functional basis, in animal experiments nicotine has been
shown to improve working memory function (Levin et al., 1994)
and attention (Hahn and Stolerman, 2002), while in humans
cognitive results are heterogeneous. Kleykamp et al. (2005) have
found no effect of nicotine gum in different doses on attention
and working memory in never-smokers. In contrast, other stud-
ies have shown that nicotine improves alerting attention-accuracy
(Barr et al., 2008), visuospatial attention (Thiel et al., 2005), and
working memory (Kumari et al., 2003) in non-smoking subjects.
However, nicotinic plasticity modulation has been explored only
in few studies in humans so far.
NICOTINIC PLASTICITY MODULATION
Recently it was shown that global cholinergic activation via
the cholinesterase-inhibitor rivastigmine enhances focal plastic-
ity induced by paired associative stimulation (PAS) and abol-
ishes/reverses non-focal facilitatory plasticity generated by tran-
scranial direct current stimulation (tDCS), thus resulting in a
focusing effect of acetylcholine on facilitatory plasticity (Kuo
et al., 2007). Similar results have been found for nicotinic effects
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in non-smokers (Thirugnanasambandam et al., 2011). However,
in difference to global cholinergic activation, nicotine reduced,
or abolished inhibitory plasticity in these subjects. In principal
accordance, nicotine enhanced the facilitatory effects of intermit-
tent theta burst stimulation in the human motor cortex (Swayne
et al., 2009). However, nicotine pharmacokinetics in the above-
mentioned study of Thirugnanasambandam et al. (2011) differ
from that present in cigarette smokers, because in that study
nicotine patches were applied, which are characterized by a slow
build-up and long duration of enhanced nicotine concentration,
whereas cigarette smoking results in a fast build-up and decay of
nicotine concentration. Since nicotinic receptor activation induces
rapid adaptive processes like desensitization (Alkondon et al.,
2000; Mansvelder and McGehee, 2000), upregulation, and greater
density of AChR (Flores et al., 1992; Mukhin et al., 2008) these
might have affected the impact of nicotine on plasticity relevantly
in that study.
PLASTICITY INDUCTION PROTOCOLS
In the present study, we therefore aimed to mimic the pharmaco-
kinetics of cigarette smoking by exploring the impact of nicotine
spray, which results in maximal nicotine plasma concentration
within a few minutes, on focal and non-focal plasticity. Facilita-
tory and inhibitory plasticity were induced by tDCS (Nitsche and
Paulus, 2000, 2001) and PAS (Stefan et al., 2000). Both stimulation
protocols induce non-invasively NMDA- and calcium channel-
dependent plasticity (Stefan et al., 2002; Nitsche et al., 2003, 2004),
though tDCS is supposed to induce non-focal plasticity changes
due to affecting large neuron populations under large electrodes
(Purpura and McMurtry, 1965; Nitsche et al., 2007), while PAS-
induced plasticity is restricted to synaptic connections between
somatosensory and motor cortex (Weise et al., 2006). As outlined
above, in non-smokers nicotine patch abolished inhibitory plas-
ticity and focused facilitatory plasticity. Since nicotine receptors
are rapidly modified by chronic nicotine exposure, we hypothe-
size that administration of a single dose of fast-acting nicotine
might affect plasticity differently as compared to nicotine patch.
MATERIALS AND METHODS
SUBJECTS
Altogether 48 otherwise healthy non-smoking subjects partici-
pated in this study. Table 1 displays the characteristics of the
subjects in terms of age and gender. All subjects were of Caucasian
origin. Chronic and acute medical diseases or any history of neuro-
logical/psychiatric disease were excluded before entering the study
by assessment of medical history, likewise intake of chronic and
acute medication. Pregnancy, family history of epilepsy, presence
of any metallic implant, or cardiac pacemaker were ruled out. All
subjects gave written informed consent before participating in the
study. The experiments were approved by the local Ethics Commit-
tee and conformed to the principles laid down in the Declaration of
Helsinki. Allocation of the subjects to the respective experimental
conditions as well as order of sessions was randomized.
PAIRED ASSOCIATIVE STIMULATION
Altogether twenty-four subjects participated in the PAS exper-
iment. Twelve non-smokers participated in the inhibitory PAS
Table 1 | Characteristics of the subjects participating in the
experiments.
Stimulation Parameter Anodal
tDCS
Cathodal
tDCS
PAS-10 PAS-25
Number of subjects 12 12 12 12
Number of females(%) 6(50) 7(58) 6(50) 6(50)
Age 24.4±
1.2
26.9±
3.6
25.9±
2.1
24.5±
1.3
S1 mV before nicotine spray 41.3 45.6 43.9 43.6
S1 mV after nicotine spray 42.3 44.9 44.4 43.3
protocol (PAS-10) and 12 in the excitatory PAS protocol (PAS-
25). Peripheral nerve stimulation was delivered to the right ulnar
nerve at the wrist level by a Digitimer D185 multipulse stimula-
tor (Digitimer, Welwyn Garden City, UK) at an intensity of 300%
of the sensory perceptual threshold followed by single pulse tran-
scranial magnetic stimulation (TMS) applied with a stimulator
output resulting in motor-evoked potentials (MEPs) of approx-
imately 1 mV amplitude (“baseline intensity,” see description in
Section “Monitoring of Cortical Excitability”). The paired pulses
were repeated 90 times at a frequency of 0.05 Hz. This proto-
col induces long-lasting excitability changes in the motor cortex
depending on the interstimulus interval (ISI). An ISI of 10 ms
induces excitability diminution (PAS-10) whereas an ISI of 25 ms
induces facilitation (PAS-25; Stefan et al., 2000; Wolters et al.,
2003). The PAS-protocols were combined with either nicotine or
placebo spray for each subject in different experimental sessions.
TRANSCRANIAL DIRECT CURRENT STIMULATION
Twenty four subjects participated in the tDCS experiments (12
non-smoking subjects participated in the inhibitory tDCS proto-
col and 12 in the excitatory tDCS protocol). We used a battery-
driven constant current stimulator (Schneider Electronics, Gle-
ichen, Germany) with a maximum output of 2 mA. tDCS was
administered via rubber electrodes covered by saline soaked
sponges (35 cm2). One electrode was positioned over the motor
cortex representational area of the right abductor digiti minimi
muscle (ADM), the other electrode above the right orbit. All sub-
jects received 1 mA of either anodal or cathodal stimulation for
13 min (anodal tDCS) or 9 min (cathodal tDCS), which had been
demonstrated to induce cortical excitability enhancement or inhi-
bition lasting for about 1 h after the end of stimulation (Nitsche
and Paulus, 2001; Nitsche et al., 2003) combined with nicotine
spray or placebo medication in different experimental sessions.
Monitoring of motor cortex excitability
Transcranial magnetic stimulation-elicited MEPs were recorded to
measure excitability changes of the representational motor corti-
cal area of the right ADM. Single pulse TMS was conducted by a
Magstim 200 magnetic stimulator (Magstim Company, Whitland,
Dyfed, UK) at a frequency of 0.25 Hz with a figure of eight-shaped
coil (diameter of one winding 70 mm, peak magnetic field, 2.2
T). The coil was held tangentially to the scalp at an angle of
45˚ to the sagittal plane with the coil handle pointing laterally
and posterior. The optimal position was defined as the site where
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stimulation resulted consistently in the largest MEPs. Surface EMG
was recorded from the right ADM with Ag–AgCl electrodes in a
belly tendon montage. The signals were amplified and filtered with
a time constant of 10 ms and a low-pass filter of 2.5 kHz, then dig-
itized at an analog-to-digital rate of 5 kHz and further relayed
into a laboratory computer using the Signal software and CED
1401 hardware (Cambridge Electronic Design). The intensity was
adjusted to elicit, on average, baseline MEPs of 1 mV peak-to-peak
amplitude, and was kept constant for the post-stimulation.
PHARMACOLOGICAL INTERVENTION
Each subject participated in two sessions in randomized order.
Nasal spray contained nicotine or inactive placebo. Nicotine was
administered by nasal spray, containing 10 mg/ml nicotine, in a
cumulative dose of 1 mg (Nicorette ®Nasal Spray, McNeil Prod-
ucts,UK) to all subjects in combination with one of the stimulation
protocols, anodal tDCS, cathodal tDCS, PAS-10, and PAS-25. The
rise time of nicotine by nasal spray in venous blood levels is close
to venous blood levels of nicotine delivered by cigarets (Schneider
et al., 1995) with a plasma peak level after 5–10 min. Side effects of
the nasal nicotinic administration were coughing, sneezing, throat
irritation, and dizziness like it has been described from prior clin-
ical trials (Sutherland et al., 1992). Symptoms subsided rapidly
after some minutes. To have a comparability to the nicotine patch
study, we chose a dose of nicotine spray (1 mg) that delivers nico-
tine blood levels comparable to those of nicotine patch (8–9 ng/ml,
see also Tønnesen et al., 1991; Pomerleau et al., 1992).
COURSE OF THE EXPERIMENT
Subjects were seated comfortably in a reclined chair with head-
and armrest and asked to relax completely. EMG electrodes were
placed at the right ADM as described above. Their exact posi-
tion was marked with a pen. Then TMS was applied over the
left representational area of the right ADM to determine the spot
with the consistently highest MEPs in the resting ADM (opti-
mal site), which was then marked with a pen. The TMS-intensity
was adjusted to elicit MEP amplitudes of 1 mV (S1 mV). Twenty
MEPs were recorded at this stimulus intensity and the mean MEP
amplitude was calculated at baseline. Then nicotine nasal spray
respective placebo spray was administered. Side effects like cough-
ing and sneezing, that could interfere with the measurements
subsided quickly and 10 min later one of the stimulation proto-
cols, either tDCS or PAS, was administered, followed by immediate
recording of at least 20 MEPs at the time points of 0, 5, 10, 15, 20,
25, 30, 60, 90, and 120 min. For the nicotine spray condition, the
after-measurements were also conducted the evening of the stim-
ulation day and in the morning and evening of the day following
the plasticity induction procedure. Sessions were conducted in
randomized order, and an inter-session interval of at least 1 week
was obligatory to avoid interferences. See also Figure 1 for course
of the experiment.
DATA ANALYSIS AND STATISTICS
For all subjects the means of 20 MEP amplitudes recorded at
each time point was calculated. The post-intervention mean MEP
amplitudes from each subject were then normalized to the respec-
tive individual mean baseline MEP amplitude (quotient of post-
vs. pre-intervention MEP amplitudes). Statistical analysis used
SPSS general linear model analysis for variances for repeated mea-
surements on normalized data. MEP amplitude was the dependent
variable including all time points up to 120 min after stimu-
lation. Drug (nicotine vs. plc) and time points were included
as within-subjects factors. Stimulation protocol (atDCS, ctDCS,
FIGURE 1 |This figure illustrates the experimental protocol of our study.
At the beginning of the session baseline measurements (BL) were performed
and followed by administration of either nicotine spray or placebo spray. After
10 min baseline (BL) motor cortical excitability was redetermined via
TMS-induced motor-evoked potentials (MEP). One of the four
excitability-inducing protocols were then applied (atDCS, ctDCS, PAS-10,
PAS-25). After-measurements started immediately after the application of the
protocols, and were conducted every 5 min for the first 30 min, then every
30 min up to 120 min for both sessions. MEP amplitudes were also recorded
the next morning and next evening for the nicotine spray sessions.
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PAS-25, and PAS-10) served as between-subject factors. Mauchly’s
sphericity test was performed and Greenhouse–Geisser correc-
tion was applied when necessary. Student’s t -tests (paired samples,
two-tailed, p< 0.05, not adjusted for multiple comparisons) were
performed to compare the MEP amplitudes before and after the
interventional brain stimulations in each condition and between
drug conditions (nicotine/placebo) for each time point. A p-value
of <0.05 was considered significant for all statistical analyses. Sig-
nificances of differences in demographic factors were tested by
one-way ANOVA and chi-square for gender. All data are expressed
as mean± standard of error (SEM).
RESULTS
All subjects tolerated the experiments well, even though nearly
all of the subjects (44 of 46 subjects, 96%) complaint about
sneezing and coughing after inhalation of nicotine spray. No
significant group differences were found in terms of age, gen-
der, TMS-intensity to elicit an MEP of 1 mV (S1 mV) before
and after administration of nicotine spray (see Table 1).
Absolute baseline MEP amplitudes did not differ significantly
within and between stimulation groups and medication con-
ditions (Student’s t -test, two-tailed, unpaired/paired, p> 0.05
for all cases). The ANOVA revealed a significant main effect
of the between-subject factor timepoint and stimulation. The
interactions drug× stimulation, timepoint× stimulation, and
drug× timepoint× stimulation were also significant (see also
Table 2 for results of degrees of freedom, F-value, p-value,
*indicates significant values with p < 0.05).
EFFECTS OF NICOTINE SPRAY ON tDCS-INDUCED PLASTICITY IN
NON-SMOKERS
In the PLC condition the anodal tDCS-induced excitability
increased MEP amplitudes stayed significant until 90 min after
stimulation,and the cathodal tDCS-induced inhibition lasted until
90 min after tDCS. As revealed by the post hoc t -test (paired,
two-tailed, p< 0.05) nicotine spray abolished the atDCS-induced
long-lasting excitability enhancements in non-smoking subjects.
For the cathodal tDCS protocol under influence of nicotine
spray excitability diminuation started delayed after 15 min and
lasted only until 20 min after stimulation. A second diminua-
tion peak could be seen after 90 min and lasted until 120 min
post-stimulation (Figure 2). Thus nicotine spray administration
delayed and weakened the ctDCS-induced after-effects.
Table 2 | Results of the ANOVA.
Parameters df F -Value p-value
Drug 1 2.288 0.138
Timepoint 6.932 2.163 0.038*
Stimulation 3 11.423 0.001*
Drug× stimulation 3 8.673 0.001*
Timepoint× stimulation 30 2.056 0.001*
Drug× timepoint 5.446 1.478 0.192
Drug× timepoint× stimulation 30 1.831 0.027*
*p<0.05
EFFECTS OF NICOTINE SPRAY ON PAS-INDUCED PLASTICITY IN
NON-SMOKERS
As revealed by Student’s t -test (paired, two-tailed, p< 0.05) in
the PLC- condition PAS-25-induced excitability changes (MEP-
enhancements) were significantly increased for up to 90 min after
stimulation, while the PAS-10-induced long-lasting after-effects
returned to baseline 120 min after PAS. Nicotine spray abolished
both the PAS-10-induced inhibitory MEP-changes and the PAS-
25-induced excitatory after-effects completely (Figure 3). Thus
nicotine spray prevented the induction of PAS-induced focal
plasticity.
EFFECT OF NICOTINE SPRAY ON MOTOR CORTEX EXCITABILITY
MEASURED BY TMS-ELICITED MOTOR-EVOKED POTENTIALS
To rule out, that nicotine spray itself increases or decreases motor
cortex excitability measured by TMS, we compared TMS-intensity
needed to elicit an MEP of 1 mV before and after the administra-
tion of nicotine spray. The respective Student’s t -test (paired, two-
tailed) did not reveal any significant difference between different
stimulation groups and before vs. after nicotine (see Figure 4).
DISCUSSION
The results of the present study show that nicotine administra-
tion has a prominent and rapidly evolving effect on stimulation-
induced neuroplasticity in the human primary motor cortex. In
non-smoking humans, nicotine spray prevented completely the
induction of focal and non-focal plasticity, as induced by PAS-25,
and anodal tDCS. Moreover it reduced excitability-diminishing
plasticity accomplished by PAS-10, whereas nicotine had no major
impact on cathodal tDCS-generated plasticity.
These results are only in partial accordance with those of a
former study in our group, where we explored the effects of long-
acting nicotine, administered via patch, on plasticity induced by
the same stimulation techniques (Thirugnanasambandam et al.,
2011). Here nicotine abolished inhibitory plasticity regardless of
its focality, whereas facilitatory plasticity was enhanced, when
the induction procedure was focal, but abolished, when it was
non-focal. Moreover, the abolishing effect of nicotine spray on
facilitatory plasticity in the present study differs prominently from
the effects of nicotine lozenge application, which enhanced facil-
itatory plasticity induced by intermittent theta burst stimulation
of the human motor cortex (Swayne et al., 2009). The comparison
between the present study and that of Thirugnanasambandam,
in which resulting nicotine plasma level should be more or less
identical, is in favor for an impact of the duration of nicotine
application on human cortical plasticity. One reason for these dif-
ferent effects of acute (in terms of minutes), and chronic (in terms
of hours) nicotine administration on plasticity might be adap-
tive receptor up- or downregulation, which takes place rapidly
in nicotinic receptors (Flores et al., 1992; Alkondon et al., 2000;
Mukhin et al., 2008; Mansvelder and McGehee 2000) and thus
might have had an impact on the results of the patch study. With
regard to the study of Swayne and co-workers, some other aspects
differ between the respective studies, such as kind of stimulation
protocol, duration of plasticity induced by the stimulation pro-
tocol alone, expected plasma level, and pharmacokinetics, which
makes a comparison between studies difficult, but nevertheless is
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FIGURE 2 | (A,B) Nicotinergic impact on transcranial direct current
stimulation (tDCS) induced neuroplasticity. Shown are the graphs with
motor evoked potentials (MEP) standardized to the baseline on theY -axis
plotted against different time points post-intervention on the X -axis. Filled
symbols indicate statistically significant deviations from baseline and
asterisks indicate significant differences between the control and nicotine
conditions (Student’s t -test, paired, two-tailed, p<0.05). nm, Next
morning; ne, next evening; plc, placebo. Tb, Baseline MEP-amplitude before
begin of the stimulation protocols (standardized). Error bars indicate
standard error of mean.
in advance for a neuromodulatory effect of nicotine on plasticity,
whose direction might be determined by diverse factors.
PROPOSED MECHANISM OF ACTION
The results of the present study allow no definite conclu-
sions about how nicotine has affected plasticity in the present
study, but some candidate mechanisms can be derived from the
more general functions of nicotinic receptors, and the physi-
ological basis of tDCS, and PAS. Nicotine binds to nicotiner-
gic ACh-receptors that are widely distributed throughout the
brain (Albuquerque et al., 2009). In the brain two major sub-
units compositions exist, the heteromeric assembly of α4β2
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FIGURE 3 | (A,B) Nicotinergic impact on paired associative stimulation (PAS)
induced neuroplasticity. Shown are the graphs with motor evoked potentials
(MEP) standardized to the baseline on theY -axis plotted against different time
points post-stimulation on the X -axis. Filled symbols indicate statistically
significant deviations from baseline and asterisks indicate significant
differences between the placebo medication and nicotine conditions
(Student’s t -test, paired, two-tailed, p<0.05). nm, Next morning; ne, next
evening; plc, placebo. Tb, Baseline MEP-amplitude before begin of the
stimulation protocols (standardized). Error bars indicate standard error of
mean.
and the homomeric α7 subunit, both exhibiting different phar-
macological and physiological properties (Jones et al., 1999),
and both increasing intracellular calcium levels by serving as
pre- and postsynaptic ligand-gated calcium channels. As the
after-effects of tDCS and PAS are likewise calcium-dependent
(Stefan et al., 2002; Nitsche et al., 2003), a possible effect of nico-
tine on neuroplasticity might be alteration of intracellular cal-
cium levels. The amount of intracellular calcium determines if
inhibitory, facilitatory, or no plasticity is induced (Lisman, 2001;
Misonou et al., 2004). Given that nicotine enhances intracellular
Frontiers in Pharmacology | Neuropharmacology October 2012 | Volume 3 | Article 186 | 6
Grundey et al. Neuroplastic changes of nicotine
FIGURE 4 | (A,B) Comparison of TMS-stimulator intensity and MEP
amplitudes before and after nicotine spray administration. Shown are the
TMS-stimulator intensity as percentage of maximum stimulator output (A)
and respective motor evoked potentials [MEP amplitudes in mV; (B)] before
and after nicotine spray administration for the different interventions (atDCS,
ctDCS, PAS-25, PAS-10). ns, Non significant; mV, millivolt.
calcium concentration via activation of the respective nicotinic
receptors, nicotine administration might have caused a calcium
concentration that overshoots the limit for LTP-like induction
elicited by atDCS and PAS-25, thus resulting in an extinction
of after-effects. The same might be true for LTD-induction
processes.
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This proposed mechanism of action is however hypothetical
and highly speculative presently and needs to be further explored
experimentally in the future. Due to the complex impact of nico-
tine on other neuromodulators and – transmitters, alternative
mechanisms of action cannot be ruled out.
GENERAL REMARKS
The results of our study demonstrate that nicotine spray influences
neuroplasticity in non-smoking humans prominently. Nicotine
spray in abolishes/reduces focal and non-focal plasticity. Here
the connection to cognitive studies is not easily drawn, since
the nicotinic effect on cognition and memory in non-smokers is
discussed controversially. A review of Heishman (1998) reported
about no true enhancement of sensory ability, selective attention,
learning, and other cognitive abilities (e.g., problem solving, rea-
soning) in non-smoking subjects. Ernst et al. (2001) describe a
nicotinic improvement of reaction time, but no effect on working
memory in non-smokers. Poltavski and Petros (2005) have even
shown a decrement in working memory in non-smokers. To fur-
ther complicate argumentation the majority of the studies have
used nicotine devices other than nicotine spray (nicotine patch,
cigarets, inhaler), thus comparability to these studies is difficult
because of different bioavailability. Only few studies have used
nicotine spray in non-smokers and have found amelioration in
rapid visual information processing (Rusted and Alvares, 2008)
and fine motor-skills (Perkins et al., 2008). Potential connections
of nicotinergic changes in LTP- and LTP-like plasticity and alter-
ations in cognitive functions in smokers and non-smokers have to
be explored more directly and intensively in the future. To clarify
the specific receptor mechanisms, different nicotinic receptor sub-
types have to be examined by pharmacological interventions (ago-
nists and antagonists). Moreover further exploration of genetic
differences between smokers and non-smokers might give further
insight into the question, why people develop a nicotine addiction.
LIMITING CONDITIONS
Some limitations of the present study should be taken into
account. The study was conducted in a single-blinded manner, so
that the person carrying out the experiments knew about the con-
dition of the subject (nicotine spray vs. placebo), thus delivering a
possible confounding factor. Furthermore, TMS-measurements of
cortical excitability were not performed until the next day in the
placebo group, which complicates evaluation of nicotinic long-
lasting effects on plasticity. Another limitation is the fact, that
we cannot exclude non-linear dose-dependent effects of nico-
tine spray, since we performed the study with a stable dose of
1 mg. Dose-related effects on cortical excitability have p.e. been
described for dopamine (Monte-Silva et al., 2009) and possible
have to be taken into account also for other substances. This
might be of special importance for the physiological effects of
neuromodulators. Another restriction is that we did not obtain
blood levels of nicotine, thus it cannot be excluded completely
that different effects of nicotine patch and spray applications on
plasticity are at least partially caused by different blood concentra-
tions. It might furthermore complicate the comparability of the
results of this study with other studies as well as cognitive testing.
Still former pharmacological studies have measured blood levels in
subjects taking 1 mg nicotine spray. With an average of 8–9 ng/ml,
the blood level did not differ from the blood levels obtained after
administration of nicotine patch 15 mg/16 h (8,9 ng/ml), which is
the dosage we had chosen for the patch study (Tønnesen et al.,
1991; Pomerleau et al., 1992; Thirugnanasambandam et al., 2011).
Moreover it should be mentioned that the explanation and dis-
cussion of the results is only hypothetical presently as currently
direct correlation to cognitive studies is still missing. Possible
future studies might test this linking between cortical excitabil-
ity changes and impact on cognitive functions more directly and
give further insight in the mechanisms of nicotine in smokers
and non-smokers. Since chronic nicotine spray administration has
fast and similar effects on craving and withdrawal symptoms than
patch (Hajek et al., 1999) it would be further interesting in future
possible studies to explore long-term effects of nicotine spray on
neuroplasticity.
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